Literature DB >> 15308387

Diabetic neuropathies.

A I Vinik1, Anahit Mehrabyan.   

Abstract

Diabetic neuropathy (DN) is a common complication of diabetes that often is associated with considerable morbidity and mortality. The epidemiology and natural history of DN is clouded with uncertainty because of confusion regarding the definition and measurement of this disorder. The recent resurgence of interest in the vascular hypothesis, oxidative stress, the neurotrophic hypothesis,and the possibility of the role of autoimmunity has opened up new avenues of investigation for therapeutic intervention. The ability to manage successfully the many different manifestations of diabetic neuropathy depends ultimately on success in uncovering the pathogenic processes underlying this disorder.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15308387     DOI: 10.1016/j.mcna.2004.04.009

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  54 in total

1.  Novel systems for in vivo monitoring and microenvironmental investigations of diabetic neuropathy in a murine model.

Authors:  Sharon Amit; Avraham Yaron
Journal:  J Neural Transm (Vienna)       Date:  2012-05-17       Impact factor: 3.575

Review 2.  Diabetic neuropathy in older adults.

Authors:  Kara A Witzke; Aaron I Vinik
Journal:  Rev Endocr Metab Disord       Date:  2005-05       Impact factor: 6.514

Review 3.  Early diabetic neuropathy: triggers and mechanisms.

Authors:  Maxim Dobretsov; Dmitry Romanovsky; Joseph R Stimers
Journal:  World J Gastroenterol       Date:  2007-01-14       Impact factor: 5.742

4.  Molecular network-based analysis of guizhi-shaoyao-zhimu decoction, a TCM herbal formula, for treatment of diabetic peripheral neuropathy.

Authors:  Ning Zhao; Jian Li; Li Li; Xu-yan Niu; Miao Jiang; Xiao-juan He; Zhao-xiang Bian; Ge Zhang; Ai-ping Lu
Journal:  Acta Pharmacol Sin       Date:  2015-04-27       Impact factor: 6.150

5.  Adenosine Monophosphate-Activated Protein Kinase Abates Hyperglycaemia-Induced Neuronal Injury in Experimental Models of Diabetic Neuropathy: Effects on Mitochondrial Biogenesis, Autophagy and Neuroinflammation.

Authors:  Veera Ganesh Yerra; Ashutosh Kumar
Journal:  Mol Neurobiol       Date:  2016-03-08       Impact factor: 5.590

6.  Risk factors and prevalence of diabetic peripheral neuropathy: A study of type 2 diabetic outpatients in Bangladesh.

Authors:  Kjersti Mørkrid; Liaquat Ali; Akhtar Hussain
Journal:  Int J Diabetes Dev Ctries       Date:  2010-01

7.  Utilization of nerve conduction studies for the diagnosis of polyneuropathy in patients with diabetes: a retrospective analysis of a large patient series.

Authors:  Xuan Kong; Eugene A Lesser; Frisso A Potts; Shai N Gozani
Journal:  J Diabetes Sci Technol       Date:  2008-03

8.  German-translated Norfolk quality of life (QOL-DN) identifies the same factors as the English version of the tool and discriminates different levels of neuropathy severity.

Authors:  Etta J Vinik; James F Paulson; Stephanie L Ford-Molvik; Aaron I Vinik
Journal:  J Diabetes Sci Technol       Date:  2008-11

9.  Potential mediators of diabetes-related hearing impairment in the U.S. population: National Health and Nutrition Examination Survey 1999-2004.

Authors:  Kathleen E Bainbridge; Yiling J Cheng; Catherine C Cowie
Journal:  Diabetes Care       Date:  2010-01-22       Impact factor: 19.112

10.  Efficacy, safety, and tolerability of Epalrestat compared to Methylcobalamine in patients with diabetic neuropathy.

Authors:  Manish Maladkar; Girish Rajadhyaksha; N Venkataswamy; R S Hariharan; Sathis R Lohati
Journal:  Int J Diabetes Dev Ctries       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.